Shelly Battista, 36, mother and IVF patient, Chicago.
Barbara Collura, president and CEO, Resolve, The National Fertility Association, McLean,VA.
Sean Tipton, chief policy and advocacy officer, American Society for Reproductive Medicine, Washington, D.C.
Contemporary OB/GYN Journal: “Not just abortion: How the demise of Roe v. Wade may impact fertility care.”
Eli Reshef, MD, reproductive endocrinologist, fertility specialists, Bennett Fertility Institute, Oklahoma City, OK.
Dean Moutos, MD, reproductive endocrinologist and medical director, Arkansas Fertility & Gynecology, Little Rock, AR.
John David Gordon, MD, reproductive endocrinologist and medical director, Southeastern Fertility Center for Fertility and Reproductive Surgery, Knoxville, TN.
Marcelle Cedars, MD, director of reproductive endocrinology, University of California San Francisco and president, American Society for Reproductive Medicine.
Art Caplan, PhD, head, division of medical ethics, NYU Grossman School of Medicine, New York.
Kara Goldman, MD, associate professor of obstetrics and medical director, fertility preservation program, Northwestern University Feinberg School of Medicine, Chicago.
Jessica King, architect and IVF patient, St. Louis, MO.
Society for Assisted Reproductive Technology, Birmingham, AL.
Resolve: “Opposing Personhood.”
Guttmacher Institute: “13 States Have Abortion Bans—Here’s What Happens When Roe Is Overturned,” “State Legislation Tracker.”
CDC: “Assisted Reproductive Technology (ART).”
ASRM: “State abortion trigger laws.”
Ohio House bill (HB) 704.